[MPI] YoY TTM Result on 31-Dec-2023 [#2]

Stock
[MPI] MALAYSIAN PACIFIC INDUSTRIES
Announcement Date
21-Feb-2024
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2024
Quarter
31-Dec-2023 [#2]
Profit Trend
QoQ- 54.95%
YoY- -83.26%
Quarter Report
Latest QR
Upcoming QR
MPI's Result
MPI's Financial Summary
View:
Show?
TTM Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 1,990,248 2,314,026 2,256,500 1,706,260 1,458,884 1,571,352 1,568,013 4.05%
PBT 98,637 322,384 421,501 260,860 181,169 218,357 227,591 -13.00%
Tax -12,420 -33,949 -46,923 -32,133 -27,054 -35,694 -32,986 -15.01%
NP 86,217 288,435 374,578 228,727 154,115 182,663 194,605 -12.68%
-
NP to SH 38,975 232,878 316,478 193,444 128,715 146,524 160,656 -21.01%
-
Tax Rate 12.59% 10.53% 11.13% 12.32% 14.93% 16.35% 14.49% -
Total Cost 1,904,031 2,025,591 1,881,922 1,477,533 1,304,769 1,388,689 1,373,408 5.59%
-
Net Worth 2,070,340 2,042,086 1,874,898 1,559,420 1,324,690 1,250,239 1,170,319 9.96%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 69,604 69,523 59,456 52,063 51,310 55,101 55,078 3.97%
Div Payout % 178.59% 29.85% 18.79% 26.91% 39.86% 37.61% 34.28% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 2,070,340 2,042,086 1,874,898 1,559,420 1,324,690 1,250,239 1,170,319 9.96%
NOSH 209,884 209,884 209,884 209,884 209,884 209,884 209,884 0.00%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 4.33% 12.46% 16.60% 13.41% 10.56% 11.62% 12.41% -
ROE 1.88% 11.40% 16.88% 12.40% 9.72% 11.72% 13.73% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 1,000.73 1,163.76 1,137.34 862.20 767.61 827.00 825.33 3.26%
EPS 19.60 117.12 159.51 97.75 67.72 77.12 84.56 -21.61%
DPS 35.00 35.00 30.00 26.31 27.00 29.00 29.00 3.18%
NAPS 10.41 10.27 9.45 7.88 6.97 6.58 6.16 9.13%
Adjusted Per Share Value based on latest NOSH - 209,884
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 948.26 1,102.53 1,075.12 812.95 695.09 748.68 747.09 4.05%
EPS 18.57 110.96 150.79 92.17 61.33 69.81 76.55 -21.01%
DPS 33.16 33.12 28.33 24.81 24.45 26.25 26.24 3.97%
NAPS 9.8642 9.7296 8.933 7.4299 6.3115 5.9568 5.576 9.96%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 28.20 28.76 49.36 25.96 11.44 9.95 12.62 -
P/RPS 2.82 2.47 4.34 3.01 1.49 1.20 1.53 10.72%
P/EPS 143.90 24.56 30.94 26.56 16.89 12.90 14.92 45.87%
EY 0.69 4.07 3.23 3.77 5.92 7.75 6.70 -31.52%
DY 1.24 1.22 0.61 1.01 2.36 2.91 2.30 -9.78%
P/NAPS 2.71 2.80 5.22 3.29 1.64 1.51 2.05 4.75%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 21/02/24 16/02/23 25/02/22 25/02/21 26/02/20 21/02/19 29/01/18 -
Price 26.18 33.74 36.00 38.00 11.20 10.22 11.24 -
P/RPS 2.62 2.90 3.17 4.41 1.46 1.24 1.36 11.54%
P/EPS 133.59 28.81 22.57 38.87 16.54 13.25 13.29 46.88%
EY 0.75 3.47 4.43 2.57 6.05 7.55 7.52 -31.88%
DY 1.34 1.04 0.83 0.69 2.41 2.84 2.58 -10.33%
P/NAPS 2.51 3.29 3.81 4.82 1.61 1.55 1.82 5.50%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment